Title : Discovery of Resorcinol-Based Polycyclic Structures as Tyrosinase Inhibitors for Treatment of Parkinson's Disease.

Pub. Date : 2022 Jan 5

PMID : 34882402






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Herein, we identified S05014 (l-Tyr, IC50 = 6.25 +- 1.43 nM; l-Dopa, IC50 = 0.64 +- 0.40 muM) as a highly effective tyrosinase inhibitor. Levodopa tyrosinase Homo sapiens